Improvement of anti-angiogenic and anti-tumourigenic efficacy of thrombospondin-1 by PPARγ ligands in bladder cancer

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
    Jeff S. Isenberg
    Gema Martin-Manso
    Justin B. Maxhimer
    David D. Roberts
    Nature Reviews Cancer, 2009, 9 : 182 - 194
  • [22] Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor
    Olga V. Volpert
    Tetiana Zaichuk
    Wei Zhou
    Frank Reiher
    Thomas A. Ferguson
    P. Michael Stuart
    Mohammad Amin
    Noel P. Bouck
    Nature Medicine, 2002, 8 : 349 - 357
  • [23] Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor
    Volpert, OV
    Zaichuk, T
    Zhou, W
    Reiher, F
    Ferguson, TA
    Stuart, PM
    Amin, M
    Bouck, NP
    NATURE MEDICINE, 2002, 8 (04) : 349 - 357
  • [24] Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
    Choi, Wonmin
    Nensel, Ashley K.
    Droho, Steven
    Fattah, Mara A.
    Mokashi-Punekar, Soumitra
    Swygart, David I.
    Burton, Spencer T.
    Schwartz, Greg W.
    Lavine, Jeremy A.
    Gianneschi, Nathan C.
    SCIENCE ADVANCES, 2023, 9 (41)
  • [25] Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: Anti-cancer efficacy
    Mousa, SA
    Mohamed, S
    ONCOLOGY REPORTS, 2004, 12 (04) : 683 - 688
  • [26] pVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines
    Javier Sevilla-Montero
    Raquel Bienes-Martínez
    David Labrousse-Arias
    Esther Fuertes-Yebra
    Ángel Ordóñez
    María J. Calzada
    Scientific Reports, 10
  • [27] pVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines
    Sevilla-Montero, Javier
    Bienes-Martinez, Raquel
    Labrousse-Arias, David
    Fuertes-Yebra, Esther
    Ordonez, Angel
    Calzada, Maria J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1
    Miao, X.
    Rahman, M. F. -U.
    Jiang, L.
    Min, Y.
    Tan, S.
    Xie, H.
    Lee, L.
    Wang, M.
    Malmstrom, R. E.
    Lui, W. -O.
    Li, N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (04) : 791 - 801
  • [29] Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
    Anders Olsson
    Anders Björk
    Johan Vallon-Christersson
    John T Isaacs
    Tomas Leanderson
    Molecular Cancer, 9
  • [30] Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
    Olsson, Anders
    Bjork, Anders
    Vallon-Christersson, Johan
    Isaacs, John T.
    Leanderson, Tomas
    MOLECULAR CANCER, 2010, 9
12345